Supplementary Table S5 from Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers
Patricia J. Keller, Elizabeth J. Adams,Rentian Wu,Alexandre Côté,Shilpi Arora,Nico Cantone,Rosana Meyer,Jennifer A. Mertz, Victor Gehling, Jike Cui, Jacob I. Stuckey,Avinash Khanna, Feng Zhao,Zehua Chen,Ziyang Yu,Richard T. Cummings, Mohammed Taimi,Nehal J. Lakhani,Drew Rasco,Martin Gutierrez,Linda Duska,Michael Devitt, Ronda Rippley, Julian Levell, Jennifer Truong, Jing Wang,Kaiming Sun,Patrick Trojer crossref（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper